iSpecimen Croissance FCF

Que fait iSpecimen ? iSpecimen Inc. is a healthcare company based in Lexington, Massachusetts, operating in the Health Care sector. The company went public on June 17, 2021, with ticker ISPC and ISIN US45032V2079. It employs 75 full-time staff members. iSpecimen provides a digital marketplace platform for the procurement of human biospecimens, connecting healthcare providers with biospecimens to researchers in biopharmaceutical, in vitro diagnostic (IVD), and academic or government institutions. The platform streamlines the biospecimen acquisition process, offering a centralized online solution for buyers and sellers. It integrates de-identified healthcare data from supply partners, supporting administrative and reporting functions for all users. The iSpecimen Marketplace is structured around four key areas: search, workflow, data, and administration and reporting. The company’s website is www.ispecimen.com. iSpecimen does not disclose specific financial figures or detailed product names beyond the marketplace platform, and it does not provide information about acquisitions, founding year, or key personnel. The company focuses on accelerating medical discovery through efficient biospecimen access. iSpecimen est l'une des entreprises les plus populaires sur Eulerpool.